Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drug, often given to patients for whom standard ...

A new lipid nanoparticle platform delivers full-length antibodies inside cells, unlocking intracellular targets in cancer, ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other ...

A cancer-targeting antibody that helps the body's immune cells spot and destroy hard-to-treat tumors such as triple-negative breast cancer has been developed by researchers. The University of ...

Bio X Cell today announces new peer-reviewed findings demonstrating that its functional antibodies maintain consistent performance across both murine in vivo models and human-relevant organoid systems ...

Nancy Klauber-DeMore, M.D., led an MUSC team that developed a highly targeted antibody therapy that, by blocking a cancer-driving protein, slowed tumor growth, reduced metastasis and re-energized the ...